Course Description

Although many clinical trial sponsors and investigators focus primarily on FDA regulations related to the conduct and design of clinical trials, their failure to comply with state laws and regulations may expose sponsors, investigators, IRBs, institutions, or individuals may call into question the potential integrity of clinical data. Today’s U.S.-based clinical trials must meet not just federal requirements, but an increasingly complex array of state specific requirements, many of which are critical and foundational to clinical studies. The capacity to consent to experimental therapy has its foundational basis and is governed by state law. In this web seminar, we will review many of these key areas, and discuss specific differences. Learners will be provided with examples from more than a dozen practical areas, including age of consent, capacity to consent, IRB and clinical protocol requirements, notification of state agencies, experimental drug dispensing requirements, HIV testing rules, genetic testing, and legal representatives. Also, we will explore strategic considerations that certain states afford specific therapeutic classes. Learners will have the opportunity to ask direct questions regarding clinical trial requirements in their research state.

Video Preview

Learning Objectives

• Recognize areas in which state-specific regulations may affect clinical trial research
• Reduce risk and liability by applying state-specific knowledge to clinical trials
• Utilize state licensing authorities and agencies to address state-specific concerns
• Describe the strategic aspects of clinical trial site selection

Who Should Attend

• Site Research Managers
• Clinical Research Associates
• Clinical Project Managers
• Principal Investigators
• Site Research Managers
• Clinical Research Coordinators

Instructor

John Serio, J.D. 

Click here for complete trainer biographies

Hold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471.